MedPath

Amydis, Inc.

Amydis, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2013-01-01
Employees
11
Market Cap
-
Website
http://www.amydis.com

Clinical Trials

4

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:1
Phase 2:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
3 (75.0%)
Phase 1
1 (25.0%)

A Study of AMDX-2011P in Participants With Alzheimer's Disease

Phase 2
Recruiting
Conditions
Alzheimer Disease
Interventions
First Posted Date
2024-07-23
Last Posted Date
2024-07-25
Lead Sponsor
Amydis Inc.
Target Recruit Count
25
Registration Number
NCT06514001
Locations
🇺🇸

Associated Retina Consultants, Phoenix, Arizona, United States

🇺🇸

Global Research Management, Glendale, California, United States

🇺🇸

Eye Research Foundation, Newport Beach, California, United States

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

Phase 2
Recruiting
Conditions
Primary Open Angle Glaucoma
Interventions
First Posted Date
2024-01-25
Last Posted Date
2024-07-30
Lead Sponsor
Amydis Inc.
Target Recruit Count
50
Registration Number
NCT06223048
Locations
🇺🇸

Associated Retina Consultants, Phoenix, Arizona, United States

🇺🇸

Global Research Management, Glendale, California, United States

🇺🇸

Eye Research Foundation, Newport Beach, California, United States

A Study of AMDX-2011P in Participants With CAA

Phase 2
Recruiting
Conditions
Cerebral Amyloid Angiopathy
Interventions
First Posted Date
2023-02-02
Last Posted Date
2024-07-30
Lead Sponsor
Amydis Inc.
Target Recruit Count
25
Registration Number
NCT05709314
Locations
🇺🇸

Associated Retina Consultants, Phoenix, Arizona, United States

🇺🇸

Global Research Management, Glendale, California, United States

🇺🇸

Eye Research Foundation, Newport Beach, California, United States

AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy

Phase 1
Recruiting
Conditions
Amyotrophic Lateral Sclerosis
Parkinson Disease
Interventions
First Posted Date
2022-09-15
Last Posted Date
2023-02-02
Lead Sponsor
Amydis Inc.
Target Recruit Count
36
Registration Number
NCT05542576
Locations
🇺🇸

Eye Research Foundation, Newport Beach, California, United States

🇺🇸

Brittany NIcholl, Pasadena, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.